MG
NVRO

Michael Gelband’s NEVRO CORP. NVRO Stock Holding History

Michael Gelband’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-126,359
Closed -$1.06M – 2189
2024
Q2 		$1.06M Sell
126,359
-216,118
-63% -$2.3M 0.01% 1005
2024
Q1 		$4.95M Buy
+342,477
New +$5.66M 0.04% 388
2023
Q3 		– Sell
-16,689
Closed -$424K – 2237
2023
Q2 		$424K Sell
16,689
-41,651
-71% -$1.2M ﹤0.01% 1416
2023
Q1 		$2.11M Buy
58,340
+8,123
+16% +$285K 0.02% 850
2022
Q4 		$1.99M Sell
50,217
-3,746
-7% -$156K 0.03% 648
2022
Q3 		$2.52M Sell
53,963
-1,531
-3% -$71.1K 0.03% 686
2022
Q2 		$2.43M Buy
+55,494
New +$3.05M 0.03% 701
2022
Q1 		– Sell
-11,106
Closed -$900K – 2754
2021
Q4 		$900K Buy
11,106
+9,020
+432% +$904K 0.01% 1131
2021
Q3 		$243K Buy
+2,086
New +$273K ﹤0.01% 1710
2021
Q2 		– Sell
-10,343
Closed -$1.44M – 2902
2021
Q1 		$1.44M Buy
+10,343
New +$1.69M 0.02% 722

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Michael Gelband's NVRO Position: Q3 2024 in Review

Michael Gelband sold out of NEVRO CORP. (NVRO) in Q3 2024, closing a stake of 126,359 shares — an estimated $1.06M sold.

Michael Gelband first reported a position in NVRO in Q1 2021 and held it in 10 quarters. The position peaked at $4.95M in Q1 2024. 131 funds tracked by Wall St. Rank hold NVRO as of Q3 2024.

  • Michael Gelband reported no remaining NEVRO CORP. position as of Q3 2024 after selling out during the quarter.
  • Michael Gelband sold 126,359 NEVRO CORP. shares in Q3 2024, an estimated $1.06M.
  • Michael Gelband first reported a position in NEVRO CORP. in Q1 2021 and held it in 10 quarters.
  • Michael Gelband's NEVRO CORP. position peaked at $4.95M in Q1 2024.
  • 131 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2024.

Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.